AK1830 oral administration and blood collection

2 trials

Sponsors

Shimizu Tomohito

Conditions

healthy subjects

Phase 1

Clinical Pharmacology Study of AK1830 (Drug-Drug Interaction Study in Healthy Men)

Active, not recruitingJPRN-jRCT2051200119

Shimizu Tomohitohealthy subjects

Start: 2021-02-07Target: 20Updated: 2026-06-29

Clinical Pharmacology Study of AK1830 (Drug-Drug Interaction Study in Healthy Men)

Active, not recruitingJPRN-jRCT2051200123

Shimizu Tomohitohealthy subjects

Start: 2021-02-26Target: 40Updated: 2026-06-29